Lupin’s US subsidiary, Lupin Pharmaceuticals Inc is recalling 11,706 bottles of Lisinopril tablets, used for treating hypertension, from the American market. The product is in the strength of 10mg.
The reason of the recall is ‘presence of foreign substance: Product complaint was received of metal contaminant observed in one tablet’. The product was distributed to distributors, mail order pharmacy and supermarkets throughout the US.
Lupin is an innovation led transnational pharmaceutical company developing and delivering a wide range of branded & generic formulations, biotechnology products and APIs globally.
